| Nicholas Crofut, CRNA | |
|
30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025-4502 | |
| (248) 258-5058 | |
| Not Available |
| Full Name | Nicholas Crofut |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 22 Years |
| Location | 30200 Telegraph Rd, Bingham Farms, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588620454 | NPI | - | NPPES |
| P00293187 | Other | MI | RAILROAD MEDICARE |
| 104822930 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 4704236483 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Edward W Sparrow Hospital | Lansing, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Edward W Sparrow Hospital Association | 6709799166 | 522 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Sparrow Clinton Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396827952 PECOS PAC ID: 5395658850 Enrollment ID: O20031111000063 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Sparrow Ionia Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700820065 PECOS PAC ID: 0042118887 Enrollment ID: O20031230000664 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235160532 PECOS PAC ID: 8527976497 Enrollment ID: O20040122000907 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Sparrow Carson Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598490542 PECOS PAC ID: 7113836701 Enrollment ID: O20040126000046 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Northstar Anesthesia Of Michigan Ii Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437268026 PECOS PAC ID: 7911895164 Enrollment ID: O20040309000625 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Edward W Sparrow Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366498107 PECOS PAC ID: 6709799166 Enrollment ID: O20040311001138 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Sparrow Ionia Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1700820065 PECOS PAC ID: 0042118887 Enrollment ID: O20060322000295 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Northwestern Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215106679 PECOS PAC ID: 4486723657 Enrollment ID: O20080514000823 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Resource Anesthesiology Associates Of Mi Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568755882 PECOS PAC ID: 4082883053 Enrollment ID: O20110808000715 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Sparrow Clinton Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1093809824 PECOS PAC ID: 5395658850 Enrollment ID: O20111222000366 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Greater Lansing Anesthesia Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114390036 PECOS PAC ID: 1850699349 Enrollment ID: O20160418000437 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Asa Staffing Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114378981 PECOS PAC ID: 3971898644 Enrollment ID: O20160818002713 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Axon Anesthesia Consultants Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235643495 PECOS PAC ID: 7012276819 Enrollment ID: O20180124003392 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Celebrity Anesthesia Staffing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235728403 PECOS PAC ID: 3678987534 Enrollment ID: O20210204001005 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Entity Name | Michigan Anesthesia Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578154050 PECOS PAC ID: 4082020631 Enrollment ID: O20210308000804 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Crofut, CRNA 806 Greenwich Dr, Grand Ledge, MI 48837-2412 Ph: () - | Nicholas Crofut, CRNA 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025-4502 Ph: (248) 258-5058 |
News Archive
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted.
An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.
› Verified 6 days ago
Michele Burke, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025 Phone: 248-258-5058 | |
Paul Santoro, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025 Phone: 248-258-5058 | |
Philip Biland, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025 Phone: 248-258-5058 | |
Timothy Marx, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025 Phone: 248-258-5058 | |
Julie Staczek-marx, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025 Phone: 248-258-5058 | |
Michael Bonds, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025 Phone: 248-258-5058 | |
Treavor Eimers, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 30200 Telegraph Rd, #220, Bingham Farms, MI 48025 Phone: 248-258-5058 Fax: 248-927-5058 |